USD 38.2 Billion
Onychomycosis Treatment Market Size, Share, Growth Analysis, By Treatment Type (Drugs, Lasers), By Disease Indication (Distal Subungual Onychomycosis, White Superficial Onychomycosis), By Age Group (18 to 39 Years, 40 to 64 Years), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35H2265 |
Region:
Global |
Published Date: November, 2024
Pages:
208
|Tables:
119
|Figures:
69
Onychomycosis Treatment Market Insights
Onychomycosis Treatment Market size was valued at USD 4.91 Billion in 2023 and is poised to grow from USD 5.33 Billion in 2024 to USD 10.32 Billion by 2032, growing at a CAGR of 8.60% during the forecast period (2025-2032).
The onychomycosis treatment market emphasizes treatments for nail fungal infections. The market comprises topical treatments, laser therapies, and oral antifungal medications. The growing cases of onychomycosis, several improvements in the treatment alternatives, and the rising awareness of the condition are majorly propelling the growth of the onychomycosis treatment market. Another key factor driving the growth of the market comprises increasing healthcare spending that allows better access to improved treatments. Nonetheless, a few restraining factors impeding the market growth include significantly priced treatment and side effects of the treatment. Most treatments, mainly advanced laser treatments and oral antifungal therapies are costly, which could lower its preference. Also, medications like itraconazole and terbinafine may cause harm to the liver and gastrointestinal issues, leading to patient hesitancy. Yet, a few opportunities witnessed in the market are innovations in drug development and improvements in drug delivery systems like nanotechnology-based products, sustained-release formulations, and highly effective topical treatments.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Distal Subungual Onychomycosis (DSO)
Fastest Growth
White Superficial Onychomycosis (WSO)
Growth Rate
5.2%
Global Onychomycosis Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Onychomycosis Treatment Market Segmental Analysis
Global Onychomycosis Treatment Market is segmented by Treatment Type, Disease Indication, Age Group, Gender, Distribution Channel, and region. Based on Treatment Type, the market is segmented into Drugs, Lasers, and Photodynamic Therapy. Based on Disease Indication, the market is segmented into Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candidal Onychomycosis, and Total Dystrophic Onychomycosis. Based on Age Group, the market is segmented into 0 to 18 Years, 19 to 39 Years, 40 to 64 Years, and 65 Years & Above. Based on Gender, the market is segmented into Male, and Female. Based on Distribution Channel, the market is segmented into Institutional Sales, and Retail Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by Type
Based on type, the Onychomycosis Treatment market is segmented as Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis. Among these, the Distal Subungual Onychomycosis (DSO) segment held a majority market in the past years and is anticipated to lead over the forecast period owing to its wide preference. It is a commonly used form of onychomycosis and hence, holds a larger share than others. It notably affects the distal area of the mail and is triggered by Trichophyton rubrum. Owing to its high prevalence, the segment is widely demanded for the said treatments.
However, the candida onychomycosis segment will hold a considerable share of the market due to its better impact on patients than others. This type of condition is caused due to candida species and is commonly seen in patients having relatively poor immune system or people who often handle water. Though less common than DSO, candida onychomycosis may hold a leading share due to the growing need for dedicated antifungal treatments.
Analysis by Distribution Channel
Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is expected to lead the market over the estimated period owing to the availability of medications and other associated facilities. These pharmacies are important for providing prescription medicines, comprising advanced therapies, and oral antifungals therapies that cannot be accessed from over-the-counter. Hospital pharmacies provide medications to patients who urgently need severe or complex treatments, mostly inpatients and dedicated outpatient settings.
On the other hand, the retail pharmacies segment will hold a leading share of the market in the coming years owing to their easy accessibility from OTC. These pharmacies supply a wide range of medications for onychomycosis treatments including lacquers, topical solutions, and other medicines and products. Quick access and convenience of such medications make retail pharmacies suitable for many patients, thus the segment growth.
Global Onychomycosis Treatment Market Size By Type
To get detailed analysis on other segments, Request For Free Sample Report
Onychomycosis Treatment Market Regional Insights
Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to the growing cases of onychomycosis due to many factors like growing prevalence of diabetes, ageing population, and lifestyle changes, especially in the leading nations like Canada and the United States. The growing awareness among the patients and the medical professionals regarding fungal infections of nail is notably contributing to the increased diagnosis and the number of treatment rates. The region is also benefitted by the high-tech healthcare infrastructure, comprising easy access to many treatment options and advanced diagnostic technologies. The key players operating in the region include Bausch Health Companies Inc., Pfizer Inc., Johnson & Johnson Services, Inc. and more.
The onychomycosis treatment market in Asia-Pacific is seen as the fastest-growing region among others due to the growing population diagnosed with onychomycosis and the rising number of patients. Asia-Pacific is witnessing diverse population, comprising nations with higher populations like India and China. This growing population is contributing to the major number of incidences of onychomycosis, thus impacting the treatment demand. Also, rising cases of onychomycosis are growing due to climate conditions, changing lifestyle, and the growing diabetic population. These factors along with enhancing healthcare infrastructure in the region are fueling the market growth.
Global Onychomycosis Treatment Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Onychomycosis Treatment Market Dynamics
Drivers
Growing Awareness, Diagnosis and Incidences of Onychomycosis
- The growing cases of fungal nail infection because of the aging population, growing diabetes cases, and growing rate of conditions that lower the immune system is fueling the growth of the onychomycosis treatment market. Moreover, the growing awareness of the condition among patients and regarding the diagnosis and advanced treatments among healthcare professionals is resulting in an increasing number of diagnoses.
Improvements in Treatment Options and Growing Healthcare Spending
- Advancements in treatment like the improvements in novel oral antifungals, laser treatments and topical therapies are fueling the growth of the market. Better efficiency, improved patient compliance, and reduced side-effects are the factors driving the market growth. In addition, increased healthcare expenses, mainly in the developing economies, are streamlining access to improved treatments. Since healthcare systems improve, the availability of the said treatment also increases.
Restraints
Limited Efficacy of the Existing Treatments
- Presently, several treatments in the market may not be thoroughly effective for all types of patients or may also have a greater rate of return (recurrence of the same disease). The treatment effectiveness may differ depending on the type and severity of the infection, resulting in the growing need for constant research and development.
Slow Diagnosis and Low Awareness
- It may be difficult for the healthcare professionals to diagnose onychomycosis since the symptoms mostly overlap with other disorders of the nail. Hence, delay in diagnosis may result in deferred treatment, which could further worsen the infection and make it complex to manage. In most of the regions, especially the emerging economies, the awareness of the treatment options may be low, thus restraining the growth of the market.
Request Free Customization of this report to help us to meet your business objectives.
Onychomycosis Treatment Market Competitive Landscape
The global Onychomycosis Treatment market is a highly competitive global market driven by a large number of international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment.
Top Player’s Company Profiles
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi S.A. (France)
- Medimetriks Pharmaceuticals, Inc. (US)
- Galderma (Switzerland)
- Johnson & Johnson (US)
- Novartis AG (Switzerland)
- Moberg Pharma AB (Sweden)
- Cardinal Health, Inc. (US)
- Pfizer Inc. (US)
- Almirall, S.A. (Spain)
- Bayer AG (Germany)
- Viatris Inc. (US)
- GlaxoSmithKline plc (UK)
- Cipla Ltd. (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Evofem Biosciences, Inc. (US)
- Nabriva Therapeutics plc (Ireland)
- Kaken Pharmaceutical Co., Ltd. (Japan)
- Hikma Pharmaceuticals PLC (UK)
- Dermavant Sciences, Inc. (US)
- Sientra, Inc. (US)
- Zynerba Pharmaceuticals, Inc. (US)
Onychomycosis Treatment Key Market Trends
- Blue Light and Carbon Dioxide Lasers: Carbon Dioxide lasers and Blue Light are adopted to cure toenail fungus, with CO2 lasers leading in adoption. These lasers can penetrate deep areas in the nail and reach the infection effectively. The blue light lasers are used for mild cases or in conjunction with different treatments, both approaches work by offering heat energy to demolish the fungus.
- Oral Antifungal Medications: Recently, there has been an inclination towards the use of novel oral antifungal agents with possible less side-effects and enhanced efficiency. For example, Terbinafine and Itraconazole are still in the market with notable preference and adoption, but the novel alternatives like Tavaborole and Efinaconazole are lately gaining importance. Moreover, blend of topical treatments with oral antifungals may enhance patient outcomes and reduce resistance risk.
Onychomycosis Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, onychomycosis treatment market growth is progressing at a notable rate and gaining popularity due to increasing cases of onychomycosis, several treatment options available and more improvements. The market is also fueled by growing healthcare infrastructure in most developing nations across the globe along with increased spending by patients for their treatments. However, the market is negatively impacted by the presently available expensive treatments, and side-effects of the treatment. North America is expected to dominate the market owing to its well-developed advanced healthcare infrastructure and strong research and development capabilities. Nonetheless, a few opportunities seen in the onychomycosis treatment market comprise the development of novel treatment alternatives and improved drug delivery systems.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 4.52 billion |
| Market size value in 2031 | USD 9.5 billion |
| Growth Rate | 8.60% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Onychomycosis Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Onychomycosis Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Onychomycosis Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Onychomycosis Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Onychomycosis Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Onychomycosis Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
